salicylic acid has been researched along with bms345541 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattarai, BR; Cho, H; Kafle, B; Kang, JH; Ko, JH; Shrestha, S | 1 |
| Chan, CB; Donath, MY; Ehses, J; Eversley, JA; Giacca, A; Ivovic, A; Karin, M; Koulajian, K; Lewis, GF; Mori, Y; Nino-Fong, R; Oprescu, AI; Volchuk, A; Wheeler, MB; Zhang, L | 1 |
2 other study(ies) available for salicylic acid and bms345541
| Article | Year |
|---|---|
Inhibition of IKK-beta: a new development in the mechanism of the anti-obesity effects of PTP1B inhibitors SA18 and SA32.
Topics: 3T3 Cells; Animals; Anti-Obesity Agents; I-kappa B Kinase; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Obesity; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2010 |
IKKβ inhibition prevents fat-induced beta cell dysfunction in vitro and in vivo in rodents.
Topics: Animals; Fatty Acids, Nonesterified; Female; I-kappa B Kinase; Imidazoles; Insulin-Secreting Cells; Mice; Oleic Acid; Oxidative Stress; Quinoxalines; Rats; Rats, Wistar; Salicylic Acid | 2017 |